J B Chemicals And Pharmaceutical share price

Balanced risk
  • 32%Low risk
  • 32%Moderate risk
  • 32%Balanced risk
  • 32%High risk
  • 32%Extreme risk
  • ₹1,561.90(2.27%)
    May 12, 2025 15:42:38 PM IST
    • NSE
    • BSE
  • Vol : 162.97K (NSE + BSE)
    Last 20 day avg : 142.97 K

J B Chemicals And Pharmaceutical is trading 2.27% upper at Rs 1,561.90 as compared to its last closing price. J B Chemicals And Pharmaceutical has been trading in the price range of 1,576.30 & 1,535.05. J B Chemicals And Pharmaceutical has given -17.33% in this year & -3.31% in the last 5 days. J B Chemicals And Pharmaceutical has TTM P/E ratio 44.73 as compared to the sector P/E of 24.41.There are 11 analysts who have initiated coverage on J B Chemicals And Pharmaceutical. There are 7 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 162.49 Crores in its last quarter.Listed peers of J B Chemicals And Pharmaceutical include Piramal Pharma (1.95%), Syngene International (1.96%), J B Chemicals And Pharmaceutical (2.27%).The Mutual Fund holding in J B Chemicals And Pharmaceutical was at 16.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in J B Chemicals And Pharmaceutical was at 18.29% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on May 12, 2025, 09:17 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.00
    Inline with the industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    8.09
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    37.90
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.24
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.13
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,535.05
Highest
1,576.30
52 week range
Lowest
1,303.00
Highest
2,029.00
J B Chemicals And Pharmaceutical News
J B Chemicals And Pharmaceutical Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 14.09% from Rs 963.49 crore to Rs 844.51 crore, year-on-year
    • financial-insightsThe company has grown its December quarter profit by 21.65% from Rs 133.57 crore to Rs 162.49 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
J B Chemicals And Pharmaceutical Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 1,663.17
  • R2
  • 1,716.08
  • R3
  • 1,800.17
Pivot1,579.08
  • S1
  • 1,526.17
  • S2
  • 1,442.08
  • S3
  • 1,389.17
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
J B Chemicals And Pharmaceutical Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Piramal Pharma
Moderately Bearish
211.951.9528,099.23451.663.470.0532.89
Syngene International
Moderately Bearish
625.751.9625,188.7552.305.210.208.65
J B Chemicals And Pharmaceutical
Bearish
1,561.902.2724,272.3143.748.090.801.14
Gland Pharma
Neutral
1,429.050.1923,501.6830.422.691.401.62
Wockhardt
Moderately Bearish
1,268.003.2620,567.99-5.59-31.59
J B Chemicals And Pharmaceutical Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for J B Chemicals And Pharmaceutical is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holding is moderate at 47.84%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 3.67 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 1.69 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    LIC MF Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 2.38
    • % of AUM 2.83
    Motilal Oswal Nifty MidSmall Healthcare Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 0.51
    • % of AUM 2.11
    LIC MF Balanced Advantage Fund Regular Growth
    3/5
    • Amount Invested (Cr.) 5.59
    • % of AUM 0.73
    Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 5.47
    • % of AUM 0.66
    LIC MF Manufacturing Fund Regular Growth
    NA
    • Amount Invested (Cr.) 3.84
    • % of AUM 0.49
    J B Chemicals And Pharmaceutical Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-14Audited Results & Final Dividend
    2025-02-04Quarterly Results & Interim Dividend
    2024-11-06Quarterly Results
    2024-08-08Quarterly Results
    2024-05-17Audited Results & Final Dividend
    About the company J B Chemicals And Pharmaceutical
    • IndustryBiotechnology & Drugs
    • ISININE572A01036
    • BSE Code506943
    • NSE CodeJBCHEPHARM
    J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing of medicated and herbal lozenges. All its lozenges (herbal, medicated and soft-centered) can be made in sugar and sugar-free options. It has implemented osmotic-controlled release oral drug delivery system (OROS) technology. It maintains a direct presence in Russia and South Africa, along with distributor relationships in the United States and various markets throughout Asia, Africa, and Latin America.
    • Management Info
    • Nikhil ChopraChief Executive Officer, Whole Time Director
    • Narayan SarafChief Financial Officer
    • Sandeep PhadnisCompany Secretary, Compliance Officer, Vice President - Secretarial
    J B Chemicals And Pharmaceutical Share Price FAQs

    J B Chemicals And Pharmaceutical is trading at 1561.90 as on Mon May 12 2025 10:12:38. This is 2.27% upper as compared to its previous closing price of 1527.30.

    The market capitalization of J B Chemicals And Pharmaceutical is 24272.31 Cr as on Mon May 12 2025 10:12:38.

    The average broker rating on J B Chemicals And Pharmaceutical is Strong Buy. The breakup of analyst rating is given below -

    • 7 analysts have given a strong buy rating
    • 2 analysts have given a buy rating
    • 1 analysts have given a hold rating
    • 1 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for J B Chemicals And Pharmaceutical is 2029.00 whereas the 52 wk low is 1303.00

    J B Chemicals And Pharmaceutical can be analyzed on the following key metrics -

    • TTM P/E: 44.73
    • Sector P/E: 24.41
    • Dividend Yield: 1.00%
    • D/E ratio: -

    J B Chemicals And Pharmaceutical reported a net profit of 552.63 Cr in 2024.

    The Mutual Fund Shareholding was 16.26% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    J B Chemicals And Pharmaceutical QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   J B Chemicals And Pharmaceutical share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.